Johnson & Johnson
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell JNJ and other ETFs, options, and stocks.About JNJ
Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments.
CEOJoaquin Duato
CEOJoaquin Duato
Employees131,900
Employees131,900
HeadquartersNew Brunswick, New Jersey
HeadquartersNew Brunswick, New Jersey
Founded1887
Founded1887
Employees131,900
Employees131,900
JNJ Key Statistics
Market cap373.54B
Market cap373.54B
Price-Earnings ratio25.65
Price-Earnings ratio25.65
Dividend yield3.13%
Dividend yield3.13%
Average volume8.38M
Average volume8.38M
High today$157.12
High today$157.12
Low today$154.11
Low today$154.11
Open price$155.89
Open price$155.89
Volume8.27M
Volume8.27M
52 Week high$168.85
52 Week high$168.85
52 Week low$143.13
52 Week low$143.13
JNJ News
Simply Wall St 18h
Read This Before Considering Johnson & Johnson For Its Upcoming US$1.24 DividendReaders hoping to buy Johnson & Johnson ( ) for its dividend will need to make their move shortly, as the stock is about to trade ex-dividend. The ex-dividend d...
Seeking Alpha 23h
Dividend Roundup: General Mills, Halliburton, Johnson & Johnson, Coca-Cola, and othersThis week's dividend activity included increased payouts from Merck (MRK) and McCormick (MKC) as well as declarations from companies such as General Mills (NYSE...
TipRanks 24h
JNJ seeks FDA approval of subcutaneous induction regimen of TremfyaJohnson & Johnson announced the submission of a supplemental Biologics License Application to the U.S. FDA seeking approval of a subcutaneous induction regimen...
Analyst ratings
50%
of 24 ratingsBuy
50%
Hold
50%
Sell
0%
More JNJ News
TipRanks 3d
Johnson & Johnson, Merck cutting jobs in China, Bloomberg reportsJohnson & Johnson (JNJ) and Merck (MRK) are cutting jobs in China as they face growing competition from domestic rivals resulting from Beijing’s campaign to dri...